Compare CEVA & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CEVA | CERT |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1576 |
| Industry | Semiconductors | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2002 | 2020 |
| Metric | CEVA | CERT |
|---|---|---|
| Price | $35.02 | $7.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $30.33 | $11.67 |
| AVG Volume (30 Days) | 598.8K | ★ 3.7M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | N/A | ★ N/A |
| Revenue | $87,507,000.00 | ★ $418,838,000.00 |
| Revenue This Year | $12.37 | $4.18 |
| Revenue Next Year | $13.82 | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 20.45 | 8.75 |
| 52 Week Low | $17.02 | $4.45 |
| 52 Week High | $51.60 | $13.88 |
| Indicator | CEVA | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 37.41 | 70.32 |
| Support Level | $18.67 | $5.93 |
| Resistance Level | $49.89 | $9.80 |
| Average True Range (ATR) | 2.65 | 0.35 |
| MACD | -0.87 | 0.03 |
| Stochastic Oscillator | 6.18 | 83.39 |
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived mainly from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems. The company operates in one reportable segment: the licensing of IP to semiconductor companies and electronic equipment manufacturers.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.